Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer

On January 22, 2021 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported an oral presentation on updated efficacy, safety, and dosing management of poziotinib from Cohorts 1 and 2 of the ZENITH20 clinical trial (Press release, Spectrum Pharmaceuticals, JAN 22, 2021, View Source [SID1234574198]). In addition, Spectrum also announced an oral presentation on the structural classification of atypical EGFR mutations and their patterns of drug sensitivity. These presentations will take place as part of the IASLC 2020 World Conference on Lung Cancer (#WCLC20) hosted by the International Association for the Study of Lung Cancer (IASLC) taking place virtually January 28-31, 2021. Details of the presentations are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Title: Updated efficacy, safety, and dosing management of poziotinib in previously treated EGFR and HER2 exon 20 NSCLC patients
Speaker: Robin Cornelissen, Ph.D., M.D.
Session: Expanding Targetable Genetic Alterations in NSCLC Mini Oral Session
Date and Time: January 31, 2021, 14:20 SGT (January 30, 2021 10:20 p.m. PT)
Presentation Number: MA11.04

Title: Structural classification of atypical EGFR mutations identifies four major subgroups with distinct patterns of drug sensitivity
Speaker: Jacqulyne P. Robichaux. Ph.D.
Session: Tumor Biology: Focus on EGFR Mutation, DNA Repair and Tumor Microenvironment Mini Oral Session
Date and Time: January 31, 2021, 17:20 SGT (January 31, 2021 1:20 a.m. PT)
Presentation Number: MA13.07

Access to the presentations is available to members of IASLC and can be found here: View Source